 |
|
|
|
|
|
|
 |
|
|
|
Brand Information
|
| Zerex Extreme Life Ready-To-Use Antifreeze/Coolant |
| liquid |
Auto Products » Cooling System » antifreeze/coolant
Auto Products » Antifreeze » cooling system
|
| 859-357-7206 |
| 2006-04-04 |
| Products with similar usage in this database |
|
|
|
|
| The following information (Health Effects, Handling/Disposal, and Ingredients) is taken from the product label and/or the Material Safety Data Sheet (MSDS) prepared by the manufacturer. The National Library of Medicine does not test products nor does it evaluate information from the product label or the MSDS.
|
|
|
|
|
Health Effects
|
|
From MSDS
HAZARDS IDENTIFICATION
Primary Route(s) of Entry: Inhalation, Skin absorption, Skin contact, Eye contact, Ingestion.
HAZARDS IDENTIFICATION
Potential Health Effects
Eye: Can cause severe eye irritation and injure eye tissue. Skin Can cause severe skin irritation. Although rare, skin contact with ethylene glycol may cause allergic skin reaction (delayed skin rash which may be followed by blistering, scaling and other skin effects). Passage through the skin may add to toxic effects from breathing or swallowing.
Swallowing: Swallowing this material may be harmful or fatal. Symptoms may include severe stomach and intestinal irritation, burns and tissue damage. Shock may occur. Liver, kidney and brain damage in humans has resulted from swallowing lethal or near-lethal amounts of ethylene glycol.
Inhalation: It is possible to breathe this material under certain conditions of handling and use (for example, during heating, spraying, or stirring). Breathing of dust, vapor, and/or mist is possible. Breathing small amounts of this material during normal handling is not likely to cause harmful effects. Breathing large amounts may be harmful. Symptoms usually occur at air concentrations higher than the recommended exposure limits.
Symptoms of Exposure Signs and symptoms of exposure to this material through breathing, swallowing, and/or passage of the material through the skin may include: stomach or intestinal upset (nausea, vomiting, diarrhea) irritation (nose, throat, airways), cough, central nervous system depression (dizziness, drowsiness, weakness, fatigue, nausea, headache, unconsciousness), central nervous system excitation (giddiness, liveliness, light-headed feeling) followed by central nervous system depression (dizziness, drowsiness, weakness, fatigue, nausea, headache, unconsciousness) and other central nervous system effects, involuntary eye movement, pain in the abdomen and lower back, cyanosis (causes blue coloring of the skin and nails from lack of oxygen), lung edema (fluid buildup in the lung tissue), acute kidney failure (sudden slowing or stopping of urine production), kidney damage, liver damage, lung damage, convulsions, coma, and death.
|
From MSDS
No information provided.
|
From MSDS
Cancer Information Based on the available information, this material cannot be classified with regard to carcinogenicity. This material is not listed as a carcinogen by the International Agency for Research on Cancer, the National Toxicology Program, or the Occupational Safety and Health Administration.
|
From MSDS
Eyes: If eye contact with liquid occurs, hold eyelids apart and flush eyes gently with lukewarm water. Seek immediate medical attention.
Skin: Remove contaminated clothing. Flush exposed area with large amounts of water. If skin is damaged, seek immediate medical attention. If skin is not damaged and symptoms persist, seek medical attention. Launder clothing before reuse.
Swallowing: Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Inhalation: If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Note to Physicians: This product contains ethylene glycol. Ethanol decreases the metabolism of ethylene glycol to toxic metabolites. Ethanol should be administered as soon as possible in cases of severe poisoning since the elimination half-life of ethylene glycol is 3 hours. If medical care will be delayed several hours, give the patient three to four 1-ounce oral "shots" of 86-proof or higher whiskey before or during transport to the hospital. Fomepizole (4-methylpyrazole) is an effective antagonist of alcohol dehydrogenase, and as such, may be used as an antidote in the treatment of ethylene glycol poisoning. Hemodialysis effectively removes ethylene glycol and its metabolites from the body. Effects of acute ethylene glycol poisoning appear in three fairly distinct stages. The initial stage occurs shortly after exposure, lasts 6-12 hours, and is characterized by central nervous system effects (transient exhilaration, nausea, vomiting, and in severe cases, coma, convulsions, and possible death. The second stage lasts from 12-36 hours after exposure and is initiated by the onset of coma. This phase is characterized by tachypnea, tachycardia, mild hypotension, cyanosis, and in severe cases, pulmonary edema, bronchopneumonia, cardiac enlargement, and congestive failure. The final stage occurs 24-72 post-exposure and is characterized by renal failure ranging from a mild increase in blood urea nitrogen and creatinine followed by recovery to complete anuria with acute tubular necrosis that can lead to death. Oxaluria is found in most cases. The most significant laboratory finding in ethylene glycol intoxication is severe metabolic acidosis. Preexisting disorders of the following organs ( or organ systems) may be aggravated by exposure to this material: skin, lung (for example, asthma-like conditions), liver kidneys, central nervous system, Exposure to this material may aggravate any pre-existing condition sensitive to a decrease in available oxygen, such as chronic lung disease, coronary artery disease or anemias.
|
| 3 |
| 1 |
| 0 |
0 = Minimal; 1 = Slight; 2 = Moderate; 3 = Serious; 4 = Severe;
N = No information provided by manufacturer; * = Chronic Health Hazard |
| 2002-07-02 |
|
|
|
|
|
|
|
|
Handling/Disposal
|
From MSDS
Containers of this material may be hazardous when emptied. Since emptied containers retain product residues (vapor, liquid, and/or solid), all hazard precautions given in the data sheet must be observed. Storage Keep containers closed when not in use.
|
From MSDS
Dispose of in accordance with all applicable local, state and federal regulations.
|
|
|
|
|
|
|
|
|
Ingredients from MSDS/Label
|
|
|
|
|
|
|
|
|
|
Home
| Brands | Manufacturers
| Ingredients | Health
Effects
|
|
